Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Locally Advanced Cervical Cancer × 30 days × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 90 Breast Neoplasms 80 Carcinoma, Non-Small-Cell Lung 33 Lung Neoplasms 32 Colorectal Neoplasms 29 Prostatic Neoplasms 26 Brain Neoplasms 22 Pancreatic Neoplasms 21 Melanoma 19 Multiple Myeloma 18 Glioblastoma 18 Neoplasm Metastasis 17 Carcinoma, Hepatocellular 17 Urinary Bladder Neoplasms 12 Stomach Neoplasms 12 Head and Neck Neoplasms 12 Glioma 12 Colonic Neoplasms 12 Uterine Cervical Neoplasms 11 Ovarian Neoplasms 11 Lymphoma, Non-Hodgkin 11 Leukemia, Myeloid, Acute 11 Carcinoma, Renal Cell 11 Neuroblastoma 10 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Endometrial Neoplasms 10 Sarcoma 9 Recurrence 9

Interventions

atezolizumab 1 Radiotherapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03612791 2026-04-03

ATEZOLACC

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Completed

Locally Advanced Cervical Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡